A Cardiff researcher has received a £2.15 million grant from Cancer Research UK to help fund the discovery of kinder treatments for head and neck cancer patients.
The aim of the study is to reduce the intensity of head and neck cancer treatment. Current treatments can result in “devastating” side-effects for some patients – including losing the ability to swallow.
The funding will go towards the PATHOS trial - a study that focuses on cancers caused by the Human Papillomavirus (HPV) virus. Anthony Butt from Penderyn took part in the trial in 2016.
The 60-year-old is now cancer free after having surgery followed by two rounds of chemotherapy and six weeks of radiotherapy.
Professor Mererid Evans, a Consultant Clinical Oncologist at Velindre Cancer Centre, is the recipient of the funding. She said the side effects of current treatment can be "devastating".
Infection with HPV increases the risk of certain types of cancers, including head and neck cancer. Around 8 out of 10 people will be affected with the virus at some point in their lives.